Table 1.

Demographic data and data pertinent to methamphetamine use and cardiovascular diseases

	Items
Demographic	Age, gender.
Drug history	Quantification of methamphetamine use: duration of regular use, time of first and last use, frequency of use, routes of administration, quantity consumed per day (if available).
	Documentation and quantification of other regularly used drugs, including all self-purchased, prescribed or over-the-counter medications.
Symptoms	Shortness of breath, chest pain, syncope, presyncope, dizziness, decreased exercise tolerance, bilateral lower limb swelling, New York Heart Association classification.
Cardiovascular risk factors and diseases	Risk factors: hypertension, diabetes mellitus, hyperlipidaemia, smoking, alcohol use.
	Diseases: coronary artery disease, peripheral artery disease, stroke, myocardial infarction, heart failure, atrial fibrillation, other conduction abnormalities, prior deep vein thrombosis/pulmonary embolism.
Blood tests	Complete blood count, renal function test, liver function test, N-terminal pro-brain natriuretic peptide/Brain natriuretic peptide, high-sensitive troponin I, creatine kinase/creatine kinase-MB, urate.